Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy

NARecruitingINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

July 12, 2024

Primary Completion Date

January 12, 2027

Study Completion Date

January 12, 2027

Conditions
Complete Heart BlockSecond Degree Atrioventricular Block Möbitz Type II
Interventions
DEVICE

Pacemaker implant

All patients in the study will have a clear indication for a permanent pacemaker. The type of device (single or dual chamber) will be chosen as per clinical practice. The only difference between the two groups of the study will be the position of the ventricular lead.

Trial Locations (6)

Unknown

NOT_YET_RECRUITING

Hospital Vall d'Hebrón, Barcelona

NOT_YET_RECRUITING

Hospital General Universitario de Castellón, Castellon

NOT_YET_RECRUITING

Hospital Virgen de las Nieves, Granada

RECRUITING

Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat

NOT_YET_RECRUITING

Hospital La Fe, Valencia

NOT_YET_RECRUITING

Hospital Lozano Blesa, Zaragoza

All Listed Sponsors
collaborator

Fundació La Marató de TV3

OTHER

collaborator

Hospital Universitari de Bellvitge

OTHER

lead

Institut d'Investigació Biomèdica de Bellvitge

OTHER